PharmacyCodes



Serpasil-Apresoline en es it fr

Serpasil-Apresoline Brand names, Serpasil-Apresoline Analogs

Serpasil-Apresoline Brand Names Mixture

  • Hydropres 25 Tab (Hydrochlorothiazide + Reserpine)
  • Hydropres 50 Tab (Hydrochlorothiazide + Reserpine)
  • SER-AP-ES Tab (Hydralazine Hydrochloride + Hydrochlorothiazide + Reserpine)

Serpasil-Apresoline Chemical_Formula

C33H40N2O9

Serpasil-Apresoline RX_link

No information avaliable

Serpasil-Apresoline fda sheet

Serpasil-Apresoline msds (material safety sheet)

Serpasil-Apresoline MSDS

Serpasil-Apresoline Synthesis Reference

No information avaliable

Serpasil-Apresoline Molecular Weight

608.679 g/mol

Serpasil-Apresoline Melting Point

264.5 oC

Serpasil-Apresoline H2O Solubility

73 mg/L

Serpasil-Apresoline State

Solid

Serpasil-Apresoline LogP

3.32

Serpasil-Apresoline Dosage Forms

Tablets

Serpasil-Apresoline Indication

Foe the treatment of hypertension

Serpasil-Apresoline Pharmacology

Reserpine is an adrenergic blocking agent used to treat mild to moderate hypertension via the disruption of norepinephrine vesicular storage. The antihypertensive actions of Reserpine are a result of its ability to deplete catecholamines from peripheral sympathetic nerve endings. These substances are normally involved in controlling heart rate, force of cardiac contraction and peripheral resistance.

Serpasil-Apresoline Absorption

No information avaliable

Serpasil-Apresoline side effects and Toxicity

Possible human carcinogen. May cause reproductive harm. ORL-RAT LD50 420 mg/kg; IPR-RAT LD50 44 mg/kg; IVN-RAT LD50 15 mg/kg; ORL-MUS LD50 200 mg/kg; SCU-MUS LD50 52 mg/kg; IPR-RBT LD50 7 mg/kg

Serpasil-Apresoline Patient Information

No information avaliable

Serpasil-Apresoline Organisms Affected

Humans and other mammals